Oklahoma City, OK2 Active Studies

Peripheral Artery Disease Clinical Trials in Oklahoma City, OK

Find 2 actively recruiting peripheral artery disease clinical trials in Oklahoma City, OK. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
250
Enrolling

Recruiting Peripheral Artery Disease Studies in Oklahoma City

About Peripheral Artery Disease Clinical Trials in Oklahoma City

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 2 peripheral artery disease clinical trials recruiting participants in Oklahoma City, OK. These studies are seeking a combined 250 participants. Research is being sponsored by University of Oklahoma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Oklahoma City — FAQ

Are there peripheral artery disease clinical trials in Oklahoma City?

Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Oklahoma City, OK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oklahoma City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.

Are clinical trials in Oklahoma City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 2 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 18, 2026 from ClinicalTrials.gov